The optogenetic promise for oncology: Episode I

Alvaro Ingles-Prieto, Eva Gschaider-Reichhart, Karin Schelch, Harald Janovjak, Michael Grusch

Research output: Contribution to journalArticleOtherpeer-review

4 Citations (Scopus)


As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.
Original languageEnglish
Article numbere964045-1
Number of pages3
JournalMolecular and Cellular Oncology
Issue number4
Publication statusPublished - 29 Oct 2014
Externally publishedYes

Cite this